[02/05/25]
Posted on February 5, 2025 in Health Law News
Published by: Hall Render
In 2024, the health care M&A marketplace remained dynamic with established industry players and disruptive new entrants engaging in a variety of transactions despite continuing inflation, fluctuating interest rates and a contentious presidential election creating significant uncertainty for providers and investors alike. As Hall Render’s Health Transactions team reflects on 2024 and looks ahead... READ MORE
Tags: Health Care Transactions, joint ventures, MA, Mergers and Acquisitions, PRIVATE EQUITY, Real Estate Transactions
[09/04/24]
Posted on September 4, 2024 in Health Law News
Published by: Hall Render
Ambulatory surgery centers (“ASCs”) continue to demonstrate strong growth nationally, as the same-day surgical care model offers advantages to both patients and providers. On the patient side, ASCs boast higher convenience and lower overall cost. For providers, well-designed and well-managed ASCs are uniquely positioned to capitalize on operational efficiencies. While offering many potential advantages,... READ MORE
Tags: Ambulatory Surgery Centers, ASC, Certificate of Need, joint ventures
[02/14/23]
Posted on February 14, 2023 in Health Law News
Published by: Hall Render
Background In a press release dated February 3, 2023, the Department of Justice’s Antitrust Division (“DOJ”) announced the withdrawal of three important policy statements that health systems and providers have relied upon for decades in ordering operations, setting internal protocols, and conducting diligence during transactions. The three policy statements include, Department of Justice and... READ MORE
Tags: Antitrust, Department of Justice’s Antitrust Division, joint ventures, Transactions
[03/26/20]
Posted on March 26, 2020 in Health Law News
Published by: Hall Render
On March 24, 2020, the Federal Trade Commission (the “FTC”) and the Antitrust Division of the Department of Justice (the “DOJ”) issued a joint statement offering an insight into the Agencies’ approach to the COVID-19 pandemic and how entities can engage in pro-competitive collaboration that does not violate the antitrust laws. While much of... READ MORE
Tags: Antitrust, COVID-19, DOJ, FTC, joint ventures